Bank of America
IMCR icon

Bank of America’s Immunocore IMCR Stock Holding History

Bank of America’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.24M Sell
206,866
-27,871
-12% -$902K ﹤0.01% 3296
2025
Q4 		$8.15M Buy
234,737
+22,912
+11% +$809K ﹤0.01% 3005
2025
Q3 		$7.7M Buy
211,825
+18,625
+10% +$633K ﹤0.01% 3576
2025
Q2 		$6.06M Sell
193,200
-102,208
-35% -$3.17M ﹤0.01% 3694
2025
Q1 		$8.76M Buy
295,408
+105,831
+56% +$3.17M ﹤0.01% 3269
2024
Q4 		$5.59M Sell
189,577
-95,362
-33% -$3.01M ﹤0.01% 3480
2024
Q3 		$8.87M Buy
284,939
+109,271
+62% +$3.97M ﹤0.01% 3186
2024
Q2 		$5.95M Sell
175,668
-28,281
-14% -$1.44M ﹤0.01% 3454
2024
Q1 		$13.3M Buy
203,949
+46,867
+30% +$3.22M ﹤0.01% 2682
2023
Q4 		$10.7M Buy
157,082
+30,920
+25% +$1.61M ﹤0.01% 2816
2023
Q3 		$6.55M Buy
126,162
+28,743
+30% +$1.7M ﹤0.01% 3148
2023
Q2 		$5.84M Buy
97,419
+96,836
+16,610% +$5.53M ﹤0.01% 3250
2023
Q1 		$28.8K Buy
583
+2
+0.3% +$112 ﹤0.01% 6653
2022
Q4 		$33.2K Sell
581
-592
-50% -$33.3K ﹤0.01% 6597
2022
Q3 		$55K Sell
1,173
-1,640
-58% -$78.2K ﹤0.01% 6629
2022
Q2 		$105K Sell
2,813
-4,019
-59% -$131K ﹤0.01% 6442
2022
Q1 		$204K Buy
6,832
+3,274
+92% +$82.6K ﹤0.01% 6447
2021
Q4 		$121K Buy
3,558
+1,305
+58% +$47.2K ﹤0.01% 6789
2021
Q3 		$84K Buy
2,253
+2,108
+1,454% +$71.1K ﹤0.01% 6815
2021
Q2 		$6K Buy
145
+45
+45% +$1.74K ﹤0.01% 7399
2021
Q1 		$4K Buy
+100
New +$4.45K ﹤0.01% 7148

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Bank of America's IMCR Position: Q1 2026 in Review

Bank of America reduced its Immunocore (IMCR) stake by 12% in Q1 2026, selling an estimated $902K and leaving 206,866 shares worth $6.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3296.

Bank of America first reported a position in IMCR in Q1 2021 and has held it in 21 quarters since. The position peaked at $13.3M in Q1 2024. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Bank of America held 206,866 shares of Immunocore worth $6.24M as of Q1 2026.
  • Bank of America sold 27,871 Immunocore shares in Q1 2026, an estimated $902K.
  • Immunocore made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3296 holding.
  • Bank of America first reported a position in Immunocore in Q1 2021 and has held it in 21 quarters since.
  • Bank of America's Immunocore position peaked at $13.3M in Q1 2024.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.